22157.jpg
United States Sexual Wellness Markets, 2021-2026 - Growing Penetration Of Digital Marketplaces | Rising Shift Towards Female Customers | Innovation In Condom Designs
21 déc. 2021 06h53 HE | Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "U.S. Sexual Wellness Market - Industry Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.The US dominated...
22157.jpg
Global Hormonal Contraceptives Market (2021 to 2030) - Featuring Bayer, Pfizer and Allergan Among Others
16 nov. 2021 07h23 HE | Research and Markets
Dublin, Nov. 16, 2021 (GLOBE NEWSWIRE) -- The "Hormonal Contraceptives Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
$31+ Billion Worldwide Gynecology Drugs Industry to 2030 - Identify Growth Segments for Investment
11 nov. 2021 06h53 HE | Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Gynecology Drugs Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. This report...
22157.jpg
Global Sexual Wellness Market (2021 to 2026) - Featuring Diamond Products, Reckitt Benckiser and Okamoto Industries Among Others
15 oct. 2021 06h23 HE | Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Sexual Wellness Market - Global Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The sexual wellness...
Agile_Logo-color on white.jpg
Agile Therapeutics Applauds Congressional Chairs’ Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act
12 oct. 2021 08h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging...
22157.jpg
Global $13.34 Bn Gynecology Drugs Markets, Competition, Forecasts & Opportunities, 2026
23 août 2021 06h13 HE | Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Gynecology Drugs Market, By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication, By Distribution Channel, By Region,...
22157.jpg
Global Contraceptives Market Report 2021: Market to Reach $29.1 Billion by 2027 - Unmet Contraception Needs Signals Huge Market Penetration Opportunities
18 août 2021 07h48 HE | Research and Markets
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Contraceptives Market to...
22157.jpg
Insights on the Contraceptives Global Market to 2028 - Increasing Awareness About Sexually Transmitted Diseases Presents Opportunities
30 juil. 2021 09h13 HE | Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel" report has been added to...
22157.jpg
Global Non-hormonal Therapies for Women's Health Market Report 2021-2030: Current Market Landscape with Focus on Prescription Drugs & Future Potential of this Evolving Market
20 juil. 2021 04h18 HE | Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
30 avr. 2021 11h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial...